iBio, Inc. ·

IBIO 8-K 2026-01-12

iBio, Inc. (IBIO) 8-K dated 2026-01-12 — accession 0001104659-26-002940. This URL is the filing, not the IBIO hub.

iBio, Inc. (IBIO) is a biotechnology company listed on US.

iBio, Inc. filed a 8-K on 2026-01-12. Accession 0001104659-26-002940.

Cached items: 1.01, 3.02, 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported IBIO revenue for 2026-06-30 was $100.0K. Net income was -$32.8M. Revenue was down 75.0% from 2025-06-30 to 2026-06-30. IBIO currently screens at market cap $13.4M.

Not investment advice. The IBIO SEC hub lists recent forms. The stock page is the research view.

Source on EDGAR